Click for best price
Antiemetics for Cancer Treatment Market Size, Share 2024
The global Antiemetics for Cancer Treatment market was valued at US$ 6.5 billionin 2023 and is projected to reach US$ 8.7 billionby 2030, at a CAGR of 4.3% during the forecast period.
The USA market for Global Antiemetics for Cancer Treatment market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Antiemetics for Cancer Treatment market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Antiemetics for Cancer Treatment market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Serotonin Receptor Antagonists Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Antiemetics for Cancer Treatment include Heron Therapeutics, Inc, Sandoz International GmbH, Merck & Co., Inc, Eisai Co., Ltd, Teva Pharmaceutical Industries Ltd, F. Hoffmann-La Roche Ltd, Mylan N.V, GSK plc and Mundipharma International, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Emetogenic symptoms are associated with nausea and vomiting associated with cancer treatments such as chemotherapy, radiation therapy, and drug therapy. Nausea and vomiting are major side effects of cancer treatment. It is important that nausea and vomiting are controlled so patients can continue treatment and have a better quality of life. Nausea and vomiting, primarily due to, can also be induced in patients receiving chemotherapy and radiation therapy of the brain, gastrointestinal tract, or liver.
This report aims to provide a comprehensive presentation of the global market for Antiemetics for Cancer Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiemetics for Cancer Treatment. This report contains market size and forecasts of Antiemetics for Cancer Treatment in global, including the following market information:
Global Antiemetics for Cancer Treatment Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Antiemetics for Cancer Treatment Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Antiemetics for Cancer Treatment companies in 2023 (%)
We has surveyed the Antiemetics for Cancer Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antiemetics for Cancer Treatment Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Antiemetics for Cancer Treatment Market Segment Percentages, by Type, 2023 (%)
- Serotonin Receptor Antagonists
- Neurokinin-1 Receptor Antagonist
- Corticosteroids
- Olanzapine
- Other
Global Antiemetics for Cancer Treatment Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Antiemetics for Cancer Treatment Market Segment Percentages, by Application, 2023 (%)
- Highly Emetogenic Chemotherapy
- Moderately Emetogenic Chemotherapy
- Low Emetogenic Chemotherapy
Global Antiemetics for Cancer Treatment Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Antiemetics for Cancer Treatment Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
The report also provides analysis of leading market participants including:
- Key companies Antiemetics for Cancer Treatment revenues in global market, 2019-2024 (Estimated), ($ millions)
- Key companies Antiemetics for Cancer Treatment revenues share in global market, 2023 (%)
- Key companies Antiemetics for Cancer Treatment sales in global market, 2019-2024 (Estimated), (K Units)
- Key companies Antiemetics for Cancer Treatment sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Heron Therapeutics, Inc
- Sandoz International GmbH
- Merck & Co., Inc
- Eisai Co., Ltd
- Teva Pharmaceutical Industries Ltd
- F. Hoffmann-La Roche Ltd
- Mylan N.V
- GSK plc
- Mundipharma International
- Baxter
- Bayer AG
- Cipla Inc
- Sanofi
- Sun Pharmaceutical Industries Ltd
- Qilu Pharmaceutical Co.,Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antiemetics for Cancer Treatment, market overview.
Chapter 2: Global Antiemetics for Cancer Treatment market size in revenue and volume.
Chapter 3: Detailed analysis of Antiemetics for Cancer Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antiemetics for Cancer Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Antiemetics for Cancer Treatment capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Antiemetics for Cancer Treatment Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
113 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Antiemetics for Cancer Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Antiemetics for Cancer Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Antiemetics for Cancer Treatment Overall Market Size
2.1 Global Antiemetics for Cancer Treatment Market Size: 2023 VS 2030
2.2 Global Antiemetics for Cancer Treatment Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Antiemetics for Cancer Treatment Sales: 2019-2030
3 Company Landscape
3.1 Top Antiemetics for Cancer Treatment Players in Global Market
3.2 Top Global Antiemetics for Cancer Treatment Companies Ranked by Revenue
3.3 Global Antiemetics for Cancer Treatment Revenue by Companies
3.4 Global Antiemetics for Cancer Treatment Sales by Companies
3.5 Global Antiemetics for Cancer Treatment Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Antiemetics for Cancer Treatment Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Antiemetics for Cancer Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antiemetics for Cancer Treatment Players in Global Market
3.8.1 List of Global Tier 1 Antiemetics for Cancer Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Antiemetics for Cancer Treatment Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Antiemetics for Cancer Treatment Market Size Markets, 2023 & 2030
4.1.2 Serotonin Receptor Antagonists
4.1.3 Neurokinin-1 Receptor Antagonist
4.1.4 Corticosteroids
4.1.5 Olanzapine
4.1.6 Other
4.2 By Type - Global Antiemetics for Cancer Treatment Revenue & Forecasts
4.2.1 By Type - Global Antiemetics for Cancer Treatment Revenue, 2019-2024
4.2.2 By Type - Global Antiemetics for Cancer Treatment Revenue, 2025-2030
4.2.3 By Type - Global Antiemetics for Cancer Treatment Revenue Market Share, 2019-2030
4.3 By Type - Global Antiemetics for Cancer Treatment Sales & Forecasts
4.3.1 By Type - Global Antiemetics for Cancer Treatment Sales, 2019-2024
4.3.2 By Type - Global Antiemetics for Cancer Treatment Sales, 2025-2030
4.3.3 By Type - Global Antiemetics for Cancer Treatment Sales Market Share, 2019-2030
4.4 By Type - Global Antiemetics for Cancer Treatment Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Antiemetics for Cancer Treatment Market Size, 2023 & 2030
5.1.2 Highly Emetogenic Chemotherapy
5.1.3 Moderately Emetogenic Chemotherapy
5.1.4 Low Emetogenic Chemotherapy
5.2 By Application - Global Antiemetics for Cancer Treatment Revenue & Forecasts
5.2.1 By Application - Global Antiemetics for Cancer Treatment Revenue, 2019-2024
5.2.2 By Application - Global Antiemetics for Cancer Treatment Revenue, 2025-2030
5.2.3 By Application - Global Antiemetics for Cancer Treatment Revenue Market Share, 2019-2030
5.3 By Application - Global Antiemetics for Cancer Treatment Sales & Forecasts
5.3.1 By Application - Global Antiemetics for Cancer Treatment Sales, 2019-2024
5.3.2 By Application - Global Antiemetics for Cancer Treatment Sales, 2025-2030
5.3.3 By Application - Global Antiemetics for Cancer Treatment Sales Market Share, 2019-2030
5.4 By Application - Global Antiemetics for Cancer Treatment Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Antiemetics for Cancer Treatment Market Size, 2023 & 2030
6.2 By Region - Global Antiemetics for Cancer Treatment Revenue & Forecasts
6.2.1 By Region - Global Antiemetics for Cancer Treatment Revenue, 2019-2024
6.2.2 By Region - Global Antiemetics for Cancer Treatment Revenue, 2025-2030
6.2.3 By Region - Global Antiemetics for Cancer Treatment Revenue Market Share, 2019-2030
6.3 By Region - Global Antiemetics for Cancer Treatment Sales & Forecasts
6.3.1 By Region - Global Antiemetics for Cancer Treatment Sales, 2019-2024
6.3.2 By Region - Global Antiemetics for Cancer Treatment Sales, 2025-2030
6.3.3 By Region - Global Antiemetics for Cancer Treatment Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Antiemetics for Cancer Treatment Revenue, 2019-2030
6.4.2 By Country - North America Antiemetics for Cancer Treatment Sales, 2019-2030
6.4.3 US Antiemetics for Cancer Treatment Market Size, 2019-2030
6.4.4 Canada Antiemetics for Cancer Treatment Market Size, 2019-2030
6.4.5 Mexico Antiemetics for Cancer Treatment Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Antiemetics for Cancer Treatment Revenue, 2019-2030
6.5.2 By Country - Europe Antiemetics for Cancer Treatment Sales, 2019-2030
6.5.3 Germany Antiemetics for Cancer Treatment Market Size, 2019-2030
6.5.4 France Antiemetics for Cancer Treatment Market Size, 2019-2030
6.5.5 U.K. Antiemetics for Cancer Treatment Market Size, 2019-2030
6.5.6 Italy Antiemetics for Cancer Treatment Market Size, 2019-2030
6.5.7 Russia Antiemetics for Cancer Treatment Market Size, 2019-2030
6.5.8 Nordic Countries Antiemetics for Cancer Treatment Market Size, 2019-2030
6.5.9 Benelux Antiemetics for Cancer Treatment Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Antiemetics for Cancer Treatment Revenue, 2019-2030
6.6.2 By Region - Asia Antiemetics for Cancer Treatment Sales, 2019-2030
6.6.3 China Antiemetics for Cancer Treatment Market Size, 2019-2030
6.6.4 Japan Antiemetics for Cancer Treatment Market Size, 2019-2030
6.6.5 South Korea Antiemetics for Cancer Treatment Market Size, 2019-2030
6.6.6 Southeast Asia Antiemetics for Cancer Treatment Market Size, 2019-2030
6.6.7 India Antiemetics for Cancer Treatment Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Antiemetics for Cancer Treatment Revenue, 2019-2030
6.7.2 By Country - South America Antiemetics for Cancer Treatment Sales, 2019-2030
6.7.3 Brazil Antiemetics for Cancer Treatment Market Size, 2019-2030
6.7.4 Argentina Antiemetics for Cancer Treatment Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Antiemetics for Cancer Treatment Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Antiemetics for Cancer Treatment Sales, 2019-2030
6.8.3 Turkey Antiemetics for Cancer Treatment Market Size, 2019-2030
6.8.4 Israel Antiemetics for Cancer Treatment Market Size, 2019-2030
6.8.5 Saudi Arabia Antiemetics for Cancer Treatment Market Size, 2019-2030
6.8.6 UAE Antiemetics for Cancer Treatment Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Heron Therapeutics, Inc
7.1.1 Heron Therapeutics, Inc Company Summary
7.1.2 Heron Therapeutics, Inc Business Overview
7.1.3 Heron Therapeutics, Inc Antiemetics for Cancer Treatment Major Product Offerings
7.1.4 Heron Therapeutics, Inc Antiemetics for Cancer Treatment Sales and Revenue in Global (2019-2024)
7.1.5 Heron Therapeutics, Inc Key News & Latest Developments
7.2 Sandoz International GmbH
7.2.1 Sandoz International GmbH Company Summary
7.2.2 Sandoz International GmbH Business Overview
7.2.3 Sandoz International GmbH Antiemetics for Cancer Treatment Major Product Offerings
7.2.4 Sandoz International GmbH Antiemetics for Cancer Treatment Sales and Revenue in Global (2019-2024)
7.2.5 Sandoz International GmbH Key News & Latest Developments
7.3 Merck & Co., Inc
7.3.1 Merck & Co., Inc Company Summary
7.3.2 Merck & Co., Inc Business Overview
7.3.3 Merck & Co., Inc Antiemetics for Cancer Treatment Major Product Offerings
7.3.4 Merck & Co., Inc Antiemetics for Cancer Treatment Sales and Revenue in Global (2019-2024)
7.3.5 Merck & Co., Inc Key News & Latest Developments
7.4 Eisai Co., Ltd
7.4.1 Eisai Co., Ltd Company Summary
7.4.2 Eisai Co., Ltd Business Overview
7.4.3 Eisai Co., Ltd Antiemetics for Cancer Treatment Major Product Offerings
7.4.4 Eisai Co., Ltd Antiemetics for Cancer Treatment Sales and Revenue in Global (2019-2024)
7.4.5 Eisai Co., Ltd Key News & Latest Developments
7.5 Teva Pharmaceutical Industries Ltd
7.5.1 Teva Pharmaceutical Industries Ltd Company Summary
7.5.2 Teva Pharmaceutical Industries Ltd Business Overview
7.5.3 Teva Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Major Product Offerings
7.5.4 Teva Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Sales and Revenue in Global (2019-2024)
7.5.5 Teva Pharmaceutical Industries Ltd Key News & Latest Developments
7.6 F. Hoffmann-La Roche Ltd
7.6.1 F. Hoffmann-La Roche Ltd Company Summary
7.6.2 F. Hoffmann-La Roche Ltd Business Overview
7.6.3 F. Hoffmann-La Roche Ltd Antiemetics for Cancer Treatment Major Product Offerings
7.6.4 F. Hoffmann-La Roche Ltd Antiemetics for Cancer Treatment Sales and Revenue in Global (2019-2024)
7.6.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.7 Mylan N.V
7.7.1 Mylan N.V Company Summary
7.7.2 Mylan N.V Business Overview
7.7.3 Mylan N.V Antiemetics for Cancer Treatment Major Product Offerings
7.7.4 Mylan N.V Antiemetics for Cancer Treatment Sales and Revenue in Global (2019-2024)
7.7.5 Mylan N.V Key News & Latest Developments
7.8 GSK plc
7.8.1 GSK plc Company Summary
7.8.2 GSK plc Business Overview
7.8.3 GSK plc Antiemetics for Cancer Treatment Major Product Offerings
7.8.4 GSK plc Antiemetics for Cancer Treatment Sales and Revenue in Global (2019-2024)
7.8.5 GSK plc Key News & Latest Developments
7.9 Mundipharma International
7.9.1 Mundipharma International Company Summary
7.9.2 Mundipharma International Business Overview
7.9.3 Mundipharma International Antiemetics for Cancer Treatment Major Product Offerings
7.9.4 Mundipharma International Antiemetics for Cancer Treatment Sales and Revenue in Global (2019-2024)
7.9.5 Mundipharma International Key News & Latest Developments
7.10 Baxter
7.10.1 Baxter Company Summary
7.10.2 Baxter Business Overview
7.10.3 Baxter Antiemetics for Cancer Treatment Major Product Offerings
7.10.4 Baxter Antiemetics for Cancer Treatment Sales and Revenue in Global (2019-2024)
7.10.5 Baxter Key News & Latest Developments
7.11 Bayer AG
7.11.1 Bayer AG Company Summary
7.11.2 Bayer AG Antiemetics for Cancer Treatment Business Overview
7.11.3 Bayer AG Antiemetics for Cancer Treatment Major Product Offerings
7.11.4 Bayer AG Antiemetics for Cancer Treatment Sales and Revenue in Global (2019-2024)
7.11.5 Bayer AG Key News & Latest Developments
7.12 Cipla Inc
7.12.1 Cipla Inc Company Summary
7.12.2 Cipla Inc Antiemetics for Cancer Treatment Business Overview
7.12.3 Cipla Inc Antiemetics for Cancer Treatment Major Product Offerings
7.12.4 Cipla Inc Antiemetics for Cancer Treatment Sales and Revenue in Global (2019-2024)
7.12.5 Cipla Inc Key News & Latest Developments
7.13 Sanofi
7.13.1 Sanofi Company Summary
7.13.2 Sanofi Antiemetics for Cancer Treatment Business Overview
7.13.3 Sanofi Antiemetics for Cancer Treatment Major Product Offerings
7.13.4 Sanofi Antiemetics for Cancer Treatment Sales and Revenue in Global (2019-2024)
7.13.5 Sanofi Key News & Latest Developments
7.14 Sun Pharmaceutical Industries Ltd
7.14.1 Sun Pharmaceutical Industries Ltd Company Summary
7.14.2 Sun Pharmaceutical Industries Ltd Business Overview
7.14.3 Sun Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Major Product Offerings
7.14.4 Sun Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Sales and Revenue in Global (2019-2024)
7.14.5 Sun Pharmaceutical Industries Ltd Key News & Latest Developments
7.15 Qilu Pharmaceutical Co.,Ltd
7.15.1 Qilu Pharmaceutical Co.,Ltd Company Summary
7.15.2 Qilu Pharmaceutical Co.,Ltd Business Overview
7.15.3 Qilu Pharmaceutical Co.,Ltd Antiemetics for Cancer Treatment Major Product Offerings
7.15.4 Qilu Pharmaceutical Co.,Ltd Antiemetics for Cancer Treatment Sales and Revenue in Global (2019-2024)
7.15.5 Qilu Pharmaceutical Co.,Ltd Key News & Latest Developments
8 Global Antiemetics for Cancer Treatment Production Capacity, Analysis
8.1 Global Antiemetics for Cancer Treatment Production Capacity, 2019-2030
8.2 Antiemetics for Cancer Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Antiemetics for Cancer Treatment Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Antiemetics for Cancer Treatment Supply Chain Analysis
10.1 Antiemetics for Cancer Treatment Industry Value Chain
10.2 Antiemetics for Cancer Treatment Upstream Market
10.3 Antiemetics for Cancer Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Antiemetics for Cancer Treatment Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Antiemetics for Cancer Treatment in Global Market
Table 2. Top Antiemetics for Cancer Treatment Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Antiemetics for Cancer Treatment Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Antiemetics for Cancer Treatment Revenue Share by Companies, 2019-2024
Table 5. Global Antiemetics for Cancer Treatment Sales by Companies, (K Units), 2019-2024
Table 6. Global Antiemetics for Cancer Treatment Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Antiemetics for Cancer Treatment Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Antiemetics for Cancer Treatment Product Type
Table 9. List of Global Tier 1 Antiemetics for Cancer Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antiemetics for Cancer Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Antiemetics for Cancer Treatment Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Antiemetics for Cancer Treatment Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Antiemetics for Cancer Treatment Sales (K Units), 2019-2024
Table 15. By Type - Global Antiemetics for Cancer Treatment Sales (K Units), 2025-2030
Table 16. By Application ? Global Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Antiemetics for Cancer Treatment Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Antiemetics for Cancer Treatment Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Antiemetics for Cancer Treatment Sales (K Units), 2019-2024
Table 20. By Application - Global Antiemetics for Cancer Treatment Sales (K Units), 2025-2030
Table 21. By Region ? Global Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Antiemetics for Cancer Treatment Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Antiemetics for Cancer Treatment Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Antiemetics for Cancer Treatment Sales (K Units), 2019-2024
Table 25. By Region - Global Antiemetics for Cancer Treatment Sales (K Units), 2025-2030
Table 26. By Country - North America Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Antiemetics for Cancer Treatment Sales, (K Units), 2019-2024
Table 29. By Country - North America Antiemetics for Cancer Treatment Sales, (K Units), 2025-2030
Table 30. By Country - Europe Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Antiemetics for Cancer Treatment Sales, (K Units), 2019-2024
Table 33. By Country - Europe Antiemetics for Cancer Treatment Sales, (K Units), 2025-2030
Table 34. By Region - Asia Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Antiemetics for Cancer Treatment Sales, (K Units), 2019-2024
Table 37. By Region - Asia Antiemetics for Cancer Treatment Sales, (K Units), 2025-2030
Table 38. By Country - South America Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Antiemetics for Cancer Treatment Sales, (K Units), 2019-2024
Table 41. By Country - South America Antiemetics for Cancer Treatment Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Antiemetics for Cancer Treatment Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Antiemetics for Cancer Treatment Sales, (K Units), 2025-2030
Table 46. Heron Therapeutics, Inc Company Summary
Table 47. Heron Therapeutics, Inc Antiemetics for Cancer Treatment Product Offerings
Table 48. Heron Therapeutics, Inc Antiemetics for Cancer Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Heron Therapeutics, Inc Key News & Latest Developments
Table 50. Sandoz International GmbH Company Summary
Table 51. Sandoz International GmbH Antiemetics for Cancer Treatment Product Offerings
Table 52. Sandoz International GmbH Antiemetics for Cancer Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Sandoz International GmbH Key News & Latest Developments
Table 54. Merck & Co., Inc Company Summary
Table 55. Merck & Co., Inc Antiemetics for Cancer Treatment Product Offerings
Table 56. Merck & Co., Inc Antiemetics for Cancer Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Merck & Co., Inc Key News & Latest Developments
Table 58. Eisai Co., Ltd Company Summary
Table 59. Eisai Co., Ltd Antiemetics for Cancer Treatment Product Offerings
Table 60. Eisai Co., Ltd Antiemetics for Cancer Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Eisai Co., Ltd Key News & Latest Developments
Table 62. Teva Pharmaceutical Industries Ltd Company Summary
Table 63. Teva Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Product Offerings
Table 64. Teva Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Teva Pharmaceutical Industries Ltd Key News & Latest Developments
Table 66. F. Hoffmann-La Roche Ltd Company Summary
Table 67. F. Hoffmann-La Roche Ltd Antiemetics for Cancer Treatment Product Offerings
Table 68. F. Hoffmann-La Roche Ltd Antiemetics for Cancer Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. F. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 70. Mylan N.V Company Summary
Table 71. Mylan N.V Antiemetics for Cancer Treatment Product Offerings
Table 72. Mylan N.V Antiemetics for Cancer Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Mylan N.V Key News & Latest Developments
Table 74. GSK plc Company Summary
Table 75. GSK plc Antiemetics for Cancer Treatment Product Offerings
Table 76. GSK plc Antiemetics for Cancer Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. GSK plc Key News & Latest Developments
Table 78. Mundipharma International Company Summary
Table 79. Mundipharma International Antiemetics for Cancer Treatment Product Offerings
Table 80. Mundipharma International Antiemetics for Cancer Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Mundipharma International Key News & Latest Developments
Table 82. Baxter Company Summary
Table 83. Baxter Antiemetics for Cancer Treatment Product Offerings
Table 84. Baxter Antiemetics for Cancer Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Baxter Key News & Latest Developments
Table 86. Bayer AG Company Summary
Table 87. Bayer AG Antiemetics for Cancer Treatment Product Offerings
Table 88. Bayer AG Antiemetics for Cancer Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. Bayer AG Key News & Latest Developments
Table 90. Cipla Inc Company Summary
Table 91. Cipla Inc Antiemetics for Cancer Treatment Product Offerings
Table 92. Cipla Inc Antiemetics for Cancer Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 93. Cipla Inc Key News & Latest Developments
Table 94. Sanofi Company Summary
Table 95. Sanofi Antiemetics for Cancer Treatment Product Offerings
Table 96. Sanofi Antiemetics for Cancer Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 97. Sanofi Key News & Latest Developments
Table 98. Sun Pharmaceutical Industries Ltd Company Summary
Table 99. Sun Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Product Offerings
Table 100. Sun Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 101. Sun Pharmaceutical Industries Ltd Key News & Latest Developments
Table 102. Qilu Pharmaceutical Co.,Ltd Company Summary
Table 103. Qilu Pharmaceutical Co.,Ltd Antiemetics for Cancer Treatment Product Offerings
Table 104. Qilu Pharmaceutical Co.,Ltd Antiemetics for Cancer Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 105. Qilu Pharmaceutical Co.,Ltd Key News & Latest Developments
Table 106. Antiemetics for Cancer Treatment Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 107. Global Antiemetics for Cancer Treatment Capacity Market Share of Key Manufacturers, 2021-2024
Table 108. Global Antiemetics for Cancer Treatment Production by Region, 2019-2024 (K Units)
Table 109. Global Antiemetics for Cancer Treatment Production by Region, 2025-2030 (K Units)
Table 110. Antiemetics for Cancer Treatment Market Opportunities & Trends in Global Market
Table 111. Antiemetics for Cancer Treatment Market Drivers in Global Market
Table 112. Antiemetics for Cancer Treatment Market Restraints in Global Market
Table 113. Antiemetics for Cancer Treatment Raw Materials
Table 114. Antiemetics for Cancer Treatment Raw Materials Suppliers in Global Market
Table 115. Typical Antiemetics for Cancer Treatment Downstream
Table 116. Antiemetics for Cancer Treatment Downstream Clients in Global Market
Table 117. Antiemetics for Cancer Treatment Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Antiemetics for Cancer Treatment Segment by Type in 2023
Figure 2. Antiemetics for Cancer Treatment Segment by Application in 2023
Figure 3. Global Antiemetics for Cancer Treatment Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Antiemetics for Cancer Treatment Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Antiemetics for Cancer Treatment Revenue, 2019-2030 (US$, Mn)
Figure 7. Antiemetics for Cancer Treatment Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Antiemetics for Cancer Treatment Revenue in 2023
Figure 9. By Type - Global Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Antiemetics for Cancer Treatment Revenue Market Share, 2019-2030
Figure 11. By Type - Global Antiemetics for Cancer Treatment Sales Market Share, 2019-2030
Figure 12. By Type - Global Antiemetics for Cancer Treatment Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Antiemetics for Cancer Treatment Revenue Market Share, 2019-2030
Figure 15. By Application - Global Antiemetics for Cancer Treatment Sales Market Share, 2019-2030
Figure 16. By Application - Global Antiemetics for Cancer Treatment Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Antiemetics for Cancer Treatment Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Antiemetics for Cancer Treatment Revenue Market Share, 2019-2030
Figure 20. By Region - Global Antiemetics for Cancer Treatment Sales Market Share, 2019-2030
Figure 21. By Country - North America Antiemetics for Cancer Treatment Revenue Market Share, 2019-2030
Figure 22. By Country - North America Antiemetics for Cancer Treatment Sales Market Share, 2019-2030
Figure 23. US Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Antiemetics for Cancer Treatment Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Antiemetics for Cancer Treatment Sales Market Share, 2019-2030
Figure 28. Germany Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 29. France Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Antiemetics for Cancer Treatment Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Antiemetics for Cancer Treatment Sales Market Share, 2019-2030
Figure 37. China Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 41. India Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Antiemetics for Cancer Treatment Revenue Market Share, 2019-2030
Figure 43. By Country - South America Antiemetics for Cancer Treatment Sales Market Share, 2019-2030
Figure 44. Brazil Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Antiemetics for Cancer Treatment Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Antiemetics for Cancer Treatment Sales Market Share, 2019-2030
Figure 48. Turkey Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Antiemetics for Cancer Treatment Revenue, (US$, Mn), 2019-2030
Figure 52. Global Antiemetics for Cancer Treatment Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Antiemetics for Cancer Treatment by Region, 2023 VS 2030
Figure 54. Antiemetics for Cancer Treatment Industry Value Chain
Figure 55. Marketing Channels
